ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
NCT02848274 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-10-22
Summary
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
Conditions
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Youn H Kim, MD · Stanford University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- United States
- Argentina
- Australia
- Brazil
- China
- Japan
- United Kingdom
Study Locations
More Related Trials
-
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
NCT03284424 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma
NCT01018004 ·Status: UNKNOWN
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
NCT05944562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
NCT05402059 ·Status: UNKNOWN
-
Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides
NCT04676087 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
NCT01187446 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides
NCT02702310 ·Status: RECRUITING
-
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
NCT00002860 ·Status: COMPLETED ·Phase: PHASE2
-
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
NCT07228442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides
NCT00630903 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma
NCT04702854 ·Status: RECRUITING ·Phase: NA
-
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
NCT04960618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Photopheresis in Early-stage Mycosis Fungoides
NCT05680558 ·Status: RECRUITING ·Phase: PHASE2
-
Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
NCT00002892 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
NCT03484923 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Photopheresis in the Treatment of Erythrodermic MF and SS
NCT03563040 ·Status: WITHDRAWN ·Phase: PHASE2
-
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
NCT01810016 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma
NCT01614301 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
NCT02828202 ·Status: RECRUITING
-
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level
NCT01396070 ·Status: COMPLETED ·Phase: PHASE2
-
Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides
NCT03281811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy
NCT02857374 ·Status: COMPLETED ·Phase: NA
-
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
NCT01886235 ·Status: COMPLETED ·Phase: NA